INCY Earnings
Latest Revenue1.7B
Latest Net Income585.6M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $2.92 | 1.7B | 585.6M | +37.7% | +39.7% |
| Q1 2026 | $1.52 | 1.3B | 303.3M | +20.9% | +85.4% |
| Q4 2025 | $1.52 | 1.5B | 299.3M | +27.8% | +46.2% |
| Q3 2025 | $2.17 | 1.4B | 424.2M | +20.0% | +294.5% |
| Q2 2025 | $2.09 | 1.2B | 405.0M | +16.5% | +202.5% |
| Q1 2025 | $0.82 | 1.1B | 158.2M | +19.5% | +7.9% |
| Q4 2024 | $1.04 | 1.2B | 201.2M | +16.3% | +15.6% |
| Q3 2024 | $0.55 | 1.1B | 106.5M | +23.8% | -27.6% |
| Q2 2024 | -$2.04 | 1.0B | -444601000 | — | — |
| Q1 2024 | $0.76 | 880.9M | 169.5M | — | — |
| Q4 2023 | $0.90 | 1.0B | 201.1M | — | — |
| Q3 2023 | $0.76 | 919.0M | 171.3M | — | — |
Incyte Genomics (INCY) — Earnings